Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2007
11/07/2007EP1461437B1 Expression vectors and promoters for heterologous gene expression
11/07/2007EP1268823B1 Methods and cells for expression of recombinant protein products
11/07/2007EP1040184B1 High expression vector for escherichia coli
11/07/2007EP1033408B1 Cold-inducible expression vector
11/07/2007EP1003379B1 Novel phytase
11/07/2007EP0950663B1 Method for stabilizing useful proteins and useful protein compositions
11/07/2007CN101068933A Fiber-modified adenoviral vectors for enhanced transduction of tumor cells
11/07/2007CN101068836A Anti-glypican 3 antibody having modified sugar chain
11/07/2007CN101067127A Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells
11/07/2007CN101067126A 新型肽生成酶基因 Generate novel peptide gene
11/07/2007CN101067125A 新型肽生成酶基因 Generate novel peptide gene
11/07/2007CN101067124A 新型肽生成酶基因 Generate novel peptide gene
11/07/2007CN101066999A Recombinant anti-OPN monoclonal antibody and its prepn and use
11/07/2007CN101066997A Human antibodies that bind human IL-12 and methods for producing
11/07/2007CN101066989A Process of separating and purifying glutathione from fermented liquid in a four-area simulated moving bed
11/07/2007CN100347306C Method and means for producing protein with prospective post-translation modification
11/07/2007CN100347304C Expression vector based on coronavirus proteolytic cleavage and its application
11/07/2007CN100347297C Process for producing human thrombin by gene modification technique
11/07/2007CN100347296C Method for manufacturing antigen-specific antibody-producing hybridomas employing a single antigen-specific b lymphocyte and method for manufacturing monoclonal antibody
11/07/2007CN100347289C Bacillus subtilis, method for preparing bacillus subtilis and its using method
11/07/2007CN100347192C Collagen and method for producing same
11/07/2007CN100347189C High-level composing production for anthrax protection antigen
11/06/2007US7291722 Polypeptide from haemophilus influenza
11/06/2007US7291721 Anti-IL-6 antibodies, compositions, methods and uses
11/06/2007US7291719 PRO4332 antibodies
11/06/2007US7291718 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders
11/06/2007US7291717 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
11/06/2007US7291716 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2007US7291715 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
11/06/2007US7291714 A non-human antibody or fragment that specifically binds to a platelet membrane glycoprotein that is involved platelet-collagen interactions
11/06/2007US7291709 LSR (Lipolysis Stimulated Receptor); for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension
11/06/2007US7291702 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
11/06/2007US7291700 PRO4985 polypeptide
11/06/2007US7291495 β-Secretase variant
11/06/2007US7291493 Expression of enzymes to increase thermotolerance by expressing them in organisms that glycosylate proteins compared to expression that the same enzyme without the glycosylation
11/06/2007US7291492 Histone deactylase for use in identifying modulators for prevention and treatment of cell proliferative disorders
11/06/2007US7291491 Polypeptides
11/06/2007US7291484 Processes for culturing E1-immortalized cells to increase product yields
11/06/2007US7291482 Transgenic microorganism comprising heterologous nucleotide sequences under control antisense agents; tissue engineering and heterologous gene expression
11/06/2007US7291479 ADAMTS-13-catalyzed proteolysis of VWF; detected by the ability of the VWF to aggregate platelets
11/06/2007US7291339 Chimeric polypeptide comprising bifunctional activities for use in medical diagnostics and monitoring protein interaction
11/06/2007US7291334 antibodies that bind to immunogens for diagnosis of enterotoxigenic E. coli infections such as traveler's diarrhea; kits
11/06/2007US7291329 Antibodies against PRO4406
11/06/2007US7291325 Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins
11/06/2007CA2363713C Lantibiotic
11/06/2007CA2126639C Milk protein partial hydrolysate and process for preparation thereof
11/06/2007CA2079881C Nucleotidic sequences coding for variable regions of .beta. chains of human t lymphocite receptors, corresponding peptidic segments and diagnostic and therapeutic applications
11/06/2007CA2079879C Nucleotidic sequences coding for alpha chain variable regions in human lymphocite receptors and applications thereof
11/01/2007WO2007124133A2 Methods and compositions based on shiga toxin type 1 protein
11/01/2007WO2007122975A1 Hgf precursor protein mutant and activated form thereof
11/01/2007WO2007122760A1 Detection reagent and detection method for influenza infection
11/01/2007WO2007122447A1 CYCLODIPEPTIDE SYNTHETASE AND ITS USE FOR SYNTHESIS OF CYCLO(TYR-Xaa) CYCLODIPEPTIDES
11/01/2007WO2007122446A1 Cyclodipeptide synthetases and their use for synthesis of cyclo(leu-leu) cyclodipeptide
11/01/2007WO2007122210A2 Proline-specific proteases free from amylolytic activities
11/01/2007WO2007083226A3 Method for selecting a peptide or polypeptide which binds to a target molecule
11/01/2007WO2007008712A8 Anti-alpha v beta 6 antibodies and uses thereof
11/01/2007WO2007005955A3 Anti-il-23 antibodies, compositions, methods and uses
11/01/2007WO2005052115A3 Use of parasitic biological agents for diseases prevention and control
11/01/2007WO2002064619A3 Peptides that inhibit poly-glutamine aggregation
11/01/2007US20070256149 Dep2 and its uses in major depressive disorder and other related disorders
11/01/2007US20070256148 DEP2 and its uses in major depressive disorder and other related disorders
11/01/2007US20070256146 Pufa polyketide synthase systems and uses thereof
11/01/2007US20070256145 Mammalian transforming growth factor beta-9
11/01/2007US20070255043 MN gene and protein
11/01/2007US20070255041 Bioengineered Vehicles for Targeted Nucleic Acid Delivery
11/01/2007US20070254844 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/01/2007US20070254836 Glycopegylated Granulocyte Colony Stimulating Factor
11/01/2007US20070254341 by organism cell biosynthesis from 6-aminohex-2-enoic acid or transform 6-amino-2-hydroxy-hexanoic acid to 6-aminohex-2-enoic acid, in presence of an enzyme having alpha, beta -enoate reductase; chemical intermediates for nylon-6 production
11/01/2007US20070254340 Biosynthesis of new cytokine
11/01/2007US20070254339 Tetramerizing polypeptides and methods of use
11/01/2007US20070254338 Method for making recombinant protein using complementation dependent DHFR mutants
11/01/2007US20070254336 Transcription Factors
11/01/2007US20070254334 Prokaryotic host cells for expressing proteins rich in disulfide bonds
11/01/2007US20070254316 Peptides for targeting the prostate specific membrane antigen
11/01/2007US20070254313 Gnal Splice Variant and Uses Thereof
11/01/2007US20070254300 Compositions and methods for treating inflammatory disorders
11/01/2007US20070254297 KCNQ2 and KCNQ3 - potassium channel genes which are mutated in Benign Familial Neonatal Convulsions (BFNC) and other epilepsies
11/01/2007US20070253973 Fusion proteins comprising alpha fetoprotein
11/01/2007US20070253966 Fusion Proteins
11/01/2007US20070253964 Novel Immunogenic Compositions for the Prevention and Treatment of Meningococcal Disease
11/01/2007US20070253963 Epithelial cell specific growth factor keratinocyte growth factor (KGF)
11/01/2007US20070253955 Methods for altering fertility
11/01/2007US20070253951 Humanized c-Kit antibody
11/01/2007US20070253947 Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
11/01/2007US20070253945 lysozyme produced from a Chalaropsis species of fungi, having a corrected amino acid sequence so as to allow recombinant production of this enzyme with a higher activity; antibacterial agent in applications wherein killing of highly resistant bacteria such as methicillin-resistant is desired
11/01/2007US20070253935 Surface expression method of peptides p5 and anal3 using the gene encoding poly-gamma-glutamate synthetase
11/01/2007CA2649800A1 Hgf precursor protein variant and active protein thereof
11/01/2007CA2649535A1 Thermostable proteins and methods of making and using thereof
11/01/2007CA2646526A1 Methods and compositions for expressing negative-sense viral rna in canine cells
10/2007
10/31/2007EP1850131A1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
10/31/2007EP1849869A2 Nucleotide sequences of HIV-1 group (or sub-group) 0 retroviral antigens
10/31/2007EP1849867A1 Preparation of antibody using mrl/lpr mouse
10/31/2007EP1849863A1 Non-human chimeric animal and use thereof
10/31/2007EP1849802A2 Methods for altering fertility
10/31/2007EP1849800A2 Moraxella catarrhalis proteins
10/31/2007EP1848812A2 Feeding buffers, systems, and methods for in vitro synthesis of biomolecules
10/31/2007EP1848672A2 Libraries and methods for isolating antibodies
10/31/2007EP1697534A4 Nucleic acid molecules containing recombination sites and methods of using the same
10/31/2007EP1678324A4 Method of in situ detection of proteins using aptamers
10/31/2007EP1509606B1 Allergen from mugwort pollen